Pasar al contenido principal

OLIGOMERIZACION DE RECEPTORES DE ADENOSINA, DOPAMINA Y GLUTAMATO EN LA ENFERMEDAD DE PARKINSON: HACIA LA IDENTIFICACION DE NUEVAS DIANAS FARMACOLOGICAS

SAF2011-24779

•
Nombre agencia financiadora Ministerio de Ciencia e Innovación
Acrónimo agencia financiadora MICINN
Programa Programa Nacional de Proyectos de Investigación Fundamental
Subprograma Subprograma de Proyectos de Investigación Fundamental no Orientada
Convocatoria Proyectos I+D
Año convocatoria 2011
Plan Estatal 2008-2011 Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica
Unidad de gestión Subdirección General de Proyectos de Investigación
Centro beneficiario UNIVERSIDAD DE BARCELONA
Identificador persistente http://dx.doi.org/10.13039/501100004837

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Photomodulation of G protein-coupled adenosine receptors by a novel light-switchable ligand

  • Bahamonde, María Isabel
  • Taura, Jaume
  • Paoletta, Silvia
  • Gakh, Anadrei A.
  • Chakraborty, Saibal
  • Hernando, Jordi|||0000-0002-1126-4138
  • Fernández-Dueñas, Víctor|||0000-0001-7834-2965
  • Jacobson, Kenneth A.|||0000-0001-8104-1493
  • Gorostiza, Pau|||0000-0002-7268-5577
  • Ciruela, Francisco|||0000-0003-0832-3739
The adenosinergic system operates through G protein-coupled adenosine receptors, which have become promising therapeutic targets for a wide range of pathological conditions. However, the ubiquity of adenosine receptors and the eventual lack of selectivity of adenosine-based drugs have frequently diminished their therapeutic potential. Accordingly, here we aimed to develop a new generation of light-switchable adenosine receptor ligands that change their intrinsic activity upon irradiation, thus allowing the spatiotemporal control of receptor functioning (i.e., receptor activation/inactivation dependent on location and timing). Therefore, we synthesized an orthosteric, photoisomerizable, and nonselective adenosine receptor agonist, nucleoside derivative MRS5543 containing an aryl diazo linkage on the N substituent, which in the dark (relaxed isomer) behaved as a full adenosine A receptor (AR) and partial adenosine A receptor (AR) agonist. Conversely, upon photoisomerization with blue light (460 nm), it remained a full AR agonist but became an AR antagonist. Interestingly, molecular modeling suggested that structural differences encountered within the third extracellular loop of each receptor could modulate the intrinsic, receptor subtype-dependent, activity. Overall, the development of adenosine receptor ligands with photoswitchable activity expands the pharmacological toolbox in support of research and possibly opens new pharmacotherapeutic opportunities.